Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: Belgium Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20093
20103
20111
20121
20131
20141
20161
20173
20182
20193
20212
20222
20232
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated8
Recruiting5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Pfizer3
Eli Lilly and Company2
Jules Bordet Institute2
Novartis Pharmaceuticals2
Puma Biotechnology, Inc.2
Stemline Therapeutics, Inc.2
BBB-Therapeutics B.V.1
Boehringer Ingelheim1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms33
Neoplasms6
Ovarian Neoplasms5
Neoplasm Metastasis4
Brain Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Endometrial Neoplasms3
Neoplasms by Site3
Triple Negative Breast Neoplasms3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.